{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:33:25Z","timestamp":1793723605340,"version":"4.6.1"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00408-020-00383-w","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T05:30:36Z","timestamp":1597123836000},"page":"735-759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5533-5105","authenticated-orcid":false,"given":"Niranjan","family":"Jeganathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheni","family":"Sathananthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"issue":"4","key":"383_CR1","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V, CTD-ILD EATFoUFo (2015) An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46(4):976\u2013987. https:\/\/doi.org\/10.1183\/13993003.00150-2015","journal-title":"Eur Respir J"},{"issue":"12","key":"383_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrrheum.2014.149","volume":"10","author":"AU Wells","year":"2014","unstructured":"Wells AU, Denton CP (2014) Interstitial lung disease in connective tissue disease\u2013mechanisms and management. Nat Rev Rheumatol 10(12):728\u2013739. https:\/\/doi.org\/10.1038\/nrrheum.2014.149","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"383_CR3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3899\/jrheum.171314","volume":"45","author":"Y Levi","year":"2018","unstructured":"Levi Y, Israeli-Shani L, Kuchuk M, Epstein Shochet G, Koslow M, Shitrit D (2018) Rheumatological assessment is important for interstitial lung disease diagnosis. J Rheumatol 45(11):1509\u20131514. https:\/\/doi.org\/10.3899\/jrheum.171314","journal-title":"J Rheumatol"},{"issue":"1","key":"383_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12931-019-0980-7","volume":"20","author":"V Cottin","year":"2019","unstructured":"Cottin V, Brown KK (2019) Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res 20(1):13. https:\/\/doi.org\/10.1186\/s12931-019-0980-7","journal-title":"Respir Res"},{"issue":"4","key":"383_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11926-014-0411-1","volume":"16","author":"T Akter","year":"2014","unstructured":"Akter T, Silver RM, Bogatkevich GS (2014) Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease. Curr Rheumatol Rep 16(4):411. https:\/\/doi.org\/10.1007\/s11926-014-0411-1","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"383_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/art.22532","volume":"57","author":"TA McNearney","year":"2007","unstructured":"McNearney TA, Reveille JD, Fischbach M, Friedman AW, Lisse JR, Goel N, Tan FK, Zhou X, Ahn C, Feghali-Bostwick CA, Fritzler M, Arnett FC, Mayes MD (2007) Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 57(2):318\u2013326. https:\/\/doi.org\/10.1002\/art.22532","journal-title":"Arthritis Rheum"},{"issue":"9","key":"383_CR7","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/art.1780370903","volume":"37","author":"VD Steen","year":"1994","unstructured":"Steen VD, Conte C, Owens GR, Medsger TA Jr (1994) Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 37(9):1283\u20131289","journal-title":"Arthritis Rheum"},{"issue":"7","key":"383_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/art.1780280706","volume":"28","author":"VD Steen","year":"1985","unstructured":"Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA Jr (1985) Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 28(7):759\u2013767","journal-title":"Arthritis Rheum"},{"issue":"3","key":"383_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","volume":"176","author":"H Schurawitzki","year":"1990","unstructured":"Schurawitzki H, Stiglbauer R, Graninger W, Herold C, Polzleitner D, Burghuber OC, Tscholakoff D (1990) Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 176(3):755\u2013759. https:\/\/doi.org\/10.1148\/radiology.176.3.2389033","journal-title":"Radiology"},{"issue":"4","key":"383_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/acr.21583","volume":"64","author":"R Steele","year":"2012","unstructured":"Steele R, Hudson M, Lo E, Baron M, Canadian Scleroderma Research G (2012) Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res (Hoboken) 64(4):519\u2013524. https:\/\/doi.org\/10.1002\/acr.21583","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"383_CR11","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1002\/art.39405","volume":"67","author":"YA Suliman","year":"2015","unstructured":"Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O (2015) Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 67(12):3256\u20133261. https:\/\/doi.org\/10.1002\/art.39405","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"383_CR12","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1164\/rccm.2106012","volume":"165","author":"D Bouros","year":"2002","unstructured":"Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165(12):1581\u20131586. https:\/\/doi.org\/10.1164\/rccm.2106012","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"383_CR13","first-page":"121","volume":"19","author":"DS Kim","year":"2002","unstructured":"Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, Kitiaichi M (2002) The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 19(2):121\u2013127","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"383_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1378\/chest.07-2444","volume":"134","author":"JG Goldin","year":"2008","unstructured":"Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, McNitt-Gray MF, Brown MS, Roth MD, Tashkin DP, Scleroderma Lung Study Research G (2008) High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 134(2):358\u2013367. https:\/\/doi.org\/10.1378\/chest.07-2444","journal-title":"Chest"},{"issue":"6","key":"383_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Muller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 66(6):754\u2013763. https:\/\/doi.org\/10.1136\/ard.2006.062901","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"383_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/art.24586","volume":"61","author":"N Fertig","year":"2009","unstructured":"Fertig N, Domsic RT, Rodriguez-Reyna T, Kuwana M, Lucas M, Medsger TA Jr, Feghali-Bostwick CA (2009) Anti-U11\/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. Arthritis Rheum 61(7):958\u2013965. https:\/\/doi.org\/10.1002\/art.24586","journal-title":"Arthritis Rheum"},{"issue":"10","key":"383_CR17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.7326\/0003-4819-119-10-199311150-00007","volume":"119","author":"Y Okano","year":"1993","unstructured":"Okano Y, Steen VD, Medsger TA Jr (1993) Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119(10):1005\u20131013","journal-title":"Ann Intern Med"},{"issue":"4","key":"383_CR18","first-page":"639","volume":"23","author":"DG Sacks","year":"1996","unstructured":"Sacks DG, Okano Y, Steen VD, Curtiss E, Shapiro LS, Medsger TA Jr (1996) Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. J Rheumatol 23(4):639\u2013642","journal-title":"J Rheumatol"},{"issue":"2","key":"383_CR19","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1186\/ar3763","volume":"14","author":"M Hudson","year":"2012","unstructured":"Hudson M, Pope J, Mahler M, Tatibouet S, Steele R, Baron M, Fritzler MJ, Canadian Scleroderma Research G (2012) Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis. Arthritis Res Ther 14(2):R50. https:\/\/doi.org\/10.1186\/ar3763","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"383_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3899\/jrheum.080633","volume":"36","author":"FN Hant","year":"2009","unstructured":"Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, Elashoff R, Tashkin DP, Silver RM, Scleroderma Lung Study Research G (2009) Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol 36(4):773\u2013780. https:\/\/doi.org\/10.3899\/jrheum.080633","journal-title":"J Rheumatol"},{"issue":"8","key":"383_CR21","first-page":"1481","volume":"32","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Kung TN, Siannis F, Pellett F, Farewell VT, Lee P (2005) HLA markers for susceptibility and expression in scleroderma. J Rheumatol 32(8):1481\u20131487","journal-title":"J Rheumatol"},{"issue":"6","key":"383_CR22","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1378\/chest.12-0110","volume":"142","author":"AL Peljto","year":"2012","unstructured":"Peljto AL, Steele MP, Fingerlin TE, Hinchcliff ME, Murphy E, Podlusky S, Carns M, Schwarz M, Varga J, Schwartz DA (2012) The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis. Chest 142(6):1584\u20131588. https:\/\/doi.org\/10.1378\/chest.12-0110","journal-title":"Chest"},{"issue":"2","key":"383_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1378\/chest.13-2626","volume":"146","author":"TA Winstone","year":"2014","unstructured":"Winstone TA, Assayag D, Wilcox PG, Dunne JV, Hague CJ, Leipsic J, Collard HR, Ryerson CJ (2014) Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review. Chest 146(2):422\u2013436. https:\/\/doi.org\/10.1378\/chest.13-2626","journal-title":"Chest"},{"issue":"11","key":"383_CR24","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177(11):1248\u20131254. https:\/\/doi.org\/10.1164\/rccm.200706-877OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"383_CR25","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/art.40130","volume":"69","author":"NS Goh","year":"2017","unstructured":"Goh NS, Hoyles RK, Denton CP, Hansell DM, Renzoni EA, Maher TM, Nicholson AG, Wells AU (2017) Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol 69(8):1670\u20131678. https:\/\/doi.org\/10.1002\/art.40130","journal-title":"Arthritis Rheumatol"},{"key":"383_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40248-019-0179-2","volume":"14","author":"N Ciancio","year":"2019","unstructured":"Ciancio N, Pavone M, Torrisi SE, Vancheri A, Sambataro D, Palmucci S, Vancheri C, Di Marco F, Sambataro G (2019) Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases. Multidiscip Respir Med 14:17. https:\/\/doi.org\/10.1186\/s40248-019-0179-2","journal-title":"Multidiscip Respir Med"},{"issue":"5","key":"383_CR27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.chest.2017.06.009","volume":"152","author":"J Morisset","year":"2017","unstructured":"Morisset J, Vittinghoff E, Elicker BM, Hu X, Le S, Ryu JH, Jones KD, Haemel A, Golden JA, Boin F, Ley B, Wolters PJ, King TE Jr, Collard HR, Lee JS (2017) Mortality risk prediction in scleroderma-related interstitial lung disease: the SADL model. Chest 152(5):999\u20131007. https:\/\/doi.org\/10.1016\/j.chest.2017.06.009","journal-title":"Chest"},{"issue":"9","key":"383_CR28","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1136\/annrheumdis-2018-213201","volume":"77","author":"W Wu","year":"2018","unstructured":"Wu W, Jordan S, Becker MO, Dobrota R, Maurer B, Fretheim H, Ye S, Siegert E, Allanore Y, Hoffmann-Vold AM, Distler O (2018) Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model. Ann Rheum Dis 77(9):1326\u20131332. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213201","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"383_CR29","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1378\/chest.15-0003","volume":"148","author":"CJ Ryerson","year":"2015","unstructured":"Ryerson CJ, O'Connor D, Dunne JV, Schooley F, Hague CJ, Murphy D, Leipsic J, Wilcox PG (2015) Predicting mortality in systemic sclerosis-associated interstitial lung disease using risk prediction models derived from idiopathic pulmonary fibrosis. Chest 148(5):1268\u20131275. https:\/\/doi.org\/10.1378\/chest.15-0003","journal-title":"Chest"},{"issue":"1","key":"383_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1164\/rccm.200705-655OC","volume":"177","author":"C Strange","year":"2008","unstructured":"Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP, Scleroderma Lung Study Research G (2008) Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med 177(1):91\u201398. https:\/\/doi.org\/10.1164\/rccm.200705-655OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"25","key":"383_CR31","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Scleroderma Lung Study Research G (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354(25):2655\u20132666. https:\/\/doi.org\/10.1056\/NEJMoa055120","journal-title":"N Engl J Med"},{"issue":"6","key":"383_CR32","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/art.22696","volume":"56","author":"NS Goh","year":"2007","unstructured":"Goh NS, Veeraraghavan S, Desai SR, Cramer D, Hansell DM, Denton CP, Black CM, du Bois RM, Wells AU (2007) Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum 56(6):2005\u20132012. https:\/\/doi.org\/10.1002\/art.22696","journal-title":"Arthritis Rheum"},{"issue":"9","key":"383_CR33","first-page":"1789","volume":"33","author":"D Launay","year":"2006","unstructured":"Launay D, Remy-Jardin M, Michon-Pasturel U, Mastora I, Hachulla E, Lambert M, Delannoy V, Queyrel V, Duhamel A, Matran R, De Groote P, Hatron PY (2006) High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 33(9):1789\u20131801","journal-title":"J Rheumatol"},{"issue":"5","key":"383_CR34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","volume":"179","author":"E Savarino","year":"2009","unstructured":"Savarino E, Bazzica M, Zentilin P, Pohl D, Parodi A, Cittadini G, Negrini S, Indiveri F, Tutuian R, Savarino V, Ghio M (2009) Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 179(5):408\u2013413. https:\/\/doi.org\/10.1164\/rccm.200808-1359OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"383_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.semarthrit.2016.02.004","volume":"46","author":"C Richardson","year":"2016","unstructured":"Richardson C, Agrawal R, Lee J, Almagor O, Nelson R, Varga J, Cuttica MJ, Dematte JD, Chang RW, Hinchcliff ME (2016) Esophageal dilatation and interstitial lung disease in systemic sclerosis: a cross-sectional study. Semin Arthritis Rheum 46(1):109\u2013114. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.02.004","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"383_CR36","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.autrev.2016.07.025","volume":"15","author":"A Morales-Cardenas","year":"2016","unstructured":"Morales-Cardenas A, Perez-Madrid C, Arias L, Ojeda P, Mahecha MP, Rojas-Villarraga A, Carrillo-Bayona JA, Anaya JM (2016) Pulmonary involvement in systemic sclerosis. Autoimmun Rev 15(11):1094\u20131108. https:\/\/doi.org\/10.1016\/j.autrev.2016.07.025","journal-title":"Autoimmun Rev"},{"issue":"2","key":"383_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1378\/chest.12-2768","volume":"144","author":"PR Bauer","year":"2013","unstructured":"Bauer PR, Schiavo DN, Osborn TG, Levin DL, St Sauver J, Hanson AC, Schroeder DR, Ryu JH (2013) Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study. Chest 144(2):571\u2013577. https:\/\/doi.org\/10.1378\/chest.12-2768","journal-title":"Chest"},{"issue":"6","key":"383_CR38","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/art.38390","volume":"66","author":"SI Nihtyanova","year":"2014","unstructured":"Nihtyanova SI, Schreiber BE, Ong VH, Rosenberg D, Moinzadeh P, Coghlan JG, Wells AU, Denton CP (2014) Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 66(6):1625\u20131635. https:\/\/doi.org\/10.1002\/art.38390","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"383_CR39","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1002\/art.30467","volume":"63","author":"D Khanna","year":"2011","unstructured":"Khanna D, Tseng CH, Farmani N, Steen V, Furst DE, Clements PJ, Roth MD, Goldin J, Elashoff R, Seibold JR, Saggar R, Tashkin DP (2011) Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group. Arthritis Rheum 63(10):3078\u20133085. https:\/\/doi.org\/10.1002\/art.30467","journal-title":"Arthritis Rheum"},{"issue":"11","key":"383_CR40","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","volume":"43","author":"VD Steen","year":"2000","unstructured":"Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437\u20132444. https:\/\/doi.org\/10.1002\/1529-0131(200011)43:11<2437:AID-ANR10>3.0.CO;2-U","journal-title":"Arthritis Rheum"},{"issue":"7","key":"383_CR41","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis 66(7):940\u2013944. https:\/\/doi.org\/10.1136\/ard.2006.066068","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"383_CR42","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Muller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumanovics G, Coleiro B, Feierl E, Szucs G, Von Muhlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kotter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809\u20131815. https:\/\/doi.org\/10.1136\/ard.2009.114264","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"383_CR43","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","volume":"176","author":"DP Tashkin","year":"2007","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Khanna D, Li N, Li G, Scleroderma Lung Study Research G (2007) Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 176(10):1026\u20131034. https:\/\/doi.org\/10.1164\/rccm.200702-326OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"383_CR44","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"DP Tashkin","year":"2016","unstructured":"Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM, Sclerodema Lung Study III (2016) Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med 4(9):708\u2013719. https:\/\/doi.org\/10.1016\/S2213-2600(16)30152-7","journal-title":"Lancet Respir Med"},{"issue":"26","key":"383_CR45","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM, Investigators ST (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 380(26):2518\u20132528. https:\/\/doi.org\/10.1056\/NEJMoa1903076","journal-title":"N Engl J Med"},{"issue":"9","key":"383_CR46","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3899\/jrheum.151322","volume":"43","author":"D Khanna","year":"2016","unstructured":"Khanna D, Albera C, Fischer A, Khalidi N, Raghu G, Chung L, Chen D, Schiopu E, Tagliaferri M, Seibold JR, Gorina E (2016) An open-label, Phase II study of the safety and tolerability of pirfenidone in patients with scleroderma-associated interstitial lung disease: the LOTUSS trial. J Rheumatol 43(9):1672\u20131679. https:\/\/doi.org\/10.3899\/jrheum.151322","journal-title":"J Rheumatol"},{"issue":"10038","key":"383_CR47","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","volume":"387","author":"D Khanna","year":"2016","unstructured":"Khanna D, Denton CP, Jahreis A, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Pope JE, Riemekasten G, Steen V, Muller-Ladner U, Lafyatis R, Stifano G, Spotswood H, Chen-Harris H, Dziadek S, Morimoto A, Sornasse T, Siegel J, Furst DE (2016) Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet 387(10038):2630\u20132640. https:\/\/doi.org\/10.1016\/S0140-6736(16)00232-4","journal-title":"Lancet"},{"issue":"2","key":"383_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/annrheumdis-2017-211682","volume":"77","author":"D Khanna","year":"2018","unstructured":"Khanna D, Denton CP, Lin CJF, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Pope JE, Riemekasten G, Steen V, Muller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE (2018) Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). Ann Rheum Dis 77(2):212\u2013220. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211682","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"383_CR49","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"311","author":"JM van Laar","year":"2014","unstructured":"van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kotter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quere I, Rich E, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socie G, Gratwohl A, Tyndall A, Group EESS (2014) Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 311(24):2490\u20132498. https:\/\/doi.org\/10.1001\/jama.2014.6368","journal-title":"JAMA"},{"issue":"1","key":"383_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1703327","volume":"378","author":"KM Sullivan","year":"2018","unstructured":"Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE, Investigators SS (2018) Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med 378(1):35\u201347","journal-title":"N Engl J Med"},{"issue":"2","key":"383_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","volume":"49","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis SN, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Sirinian C, Karampetsou M, Yiannopoulos G, Andonopoulos AP (2010) Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology (Oxford) 49(2):271\u2013280. https:\/\/doi.org\/10.1093\/rheumatology\/kep093","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"383_CR52","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","volume":"74","author":"S Jordan","year":"2015","unstructured":"Jordan S, Distler JH, Maurer B, Huscher D, van Laar JM, Allanore Y, Distler O, group ERs (2015) Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis 74(6):1188\u20131194. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204522","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"383_CR53","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","volume":"41","author":"VD Steen","year":"1998","unstructured":"Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41(9):1613\u20131619. https:\/\/doi.org\/10.1002\/1529-0131(199809)41:9<1613:AID-ART11>3.0.CO;2-O","journal-title":"Arthritis Rheum"},{"issue":"2","key":"383_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.resinv.2012.12.002","volume":"51","author":"K Ando","year":"2013","unstructured":"Ando K, Motojima S, Doi T, Nagaoka T, Kaneko N, Aoshima M, Takahashi K (2013) Effect of glucocorticoid monotherapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung disease. Respir Investig 51(2):69\u201375. https:\/\/doi.org\/10.1016\/j.resinv.2012.12.002","journal-title":"Respir Investig"},{"issue":"2","key":"383_CR55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10067-005-1157-y","volume":"25","author":"O Nadashkevich","year":"2006","unstructured":"Nadashkevich O, Davis P, Fritzler M, Kovalenko W (2006) A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis. Clin Rheumatol 25(2):205\u2013212. https:\/\/doi.org\/10.1007\/s10067-005-1157-y","journal-title":"Clin Rheumatol"},{"issue":"12","key":"383_CR56","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/art.22204","volume":"54","author":"RK Hoyles","year":"2006","unstructured":"Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM (2006) A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 54(12):3962\u20133970. https:\/\/doi.org\/10.1002\/art.22204","journal-title":"Arthritis Rheum"},{"key":"383_CR57","doi-asserted-by":"crossref","unstructured":"Miele CH, Schwab K, Saggar R, Duffy E, Elashoff D, Tseng CH, Weigt S, Charan D, Abtin F, Johannes J, Derhovanessian A, Conklin J, Ghassemi K, Khanna D, Siddiqui O, Ardehali A, Hunter C, Kwon M, Biniwale R, Lo M, Volkmann E, Torres Barba D, Belperio JA, Sayah D, Mahrer T, Furst DE, Kafaja S, Clements P, Shino M, Gregson A, Kubak B, Lynch JP, 3rd, Ross D, Saggar R (2016) Lung transplant outcomes in systemic sclerosis with significant esophageal dysfunction. A comprehensive single-center experience. Ann Am Thorac Soc 13(6):793\u2013802.","DOI":"10.1513\/AnnalsATS.201512-806OC"},{"issue":"7","key":"383_CR58","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.healun.2018.03.003","volume":"37","author":"P Pradere","year":"2018","unstructured":"Pradere P, Tudorache I, Magnusson J, Savale L, Brugiere O, Douvry B, Reynaud-Gaubert M, Claustre J, Borgne AL, Holm AM, Schultz HH, Knoop C, Godinas L, Fisher AJ, Hirschi S, Gottlieb J, Le Pavec J, Working Group on Heart\/Lung Transplantation in Systemic S (2018) Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study. J Heart Lung Transpl 37(7):903\u2013911. https:\/\/doi.org\/10.1016\/j.healun.2018.03.003","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"383_CR59","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccm.2019.05.003","volume":"40","author":"AJ Esposito","year":"2019","unstructured":"Esposito AJ, Chu SG, Madan R, Doyle TJ, Dellaripa PF (2019) Thoracic manifestations of rheumatoid arthritis. Clin Chest Med 40(3):545\u2013560. https:\/\/doi.org\/10.1016\/j.ccm.2019.05.003","journal-title":"Clin Chest Med"},{"issue":"4","key":"383_CR60","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0272-5231(05)70109-X","volume":"19","author":"LT Tanoue","year":"1998","unstructured":"Tanoue LT (1998) Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med 19(4):667\u2013685","journal-title":"Clin Chest Med"},{"issue":"6","key":"383_CR61","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","volume":"127","author":"HK Lee","year":"2005","unstructured":"Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, Kitaichi M (2005) Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127(6):2019\u20132027. https:\/\/doi.org\/10.1378\/chest.127.6.2019","journal-title":"Chest"},{"issue":"4","key":"383_CR62","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3899\/jrheum.171315","volume":"46","author":"K Raimundo","year":"2019","unstructured":"Raimundo K, Solomon JJ, Olson AL, Kong AM, Cole AL, Fischer A, Swigris JJ (2019) Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality. J Rheumatol 46(4):360\u2013369. https:\/\/doi.org\/10.3899\/jrheum.171315","journal-title":"J Rheumatol"},{"issue":"2 Pt 1","key":"383_CR63","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","volume":"156","author":"E Gabbay","year":"1997","unstructured":"Gabbay E, Tarala R, Will R, Carroll G, Adler B, Cameron D, Lake FR (1997) Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 156(2 Pt 1):528\u2013535. https:\/\/doi.org\/10.1164\/ajrccm.156.2.9609016","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"383_CR64","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","volume":"30","author":"HM Habib","year":"2011","unstructured":"Habib HM, Eisa AA, Arafat WR, Marie MA (2011) Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol 30(2):217\u2013221. https:\/\/doi.org\/10.1007\/s10067-010-1492-5","journal-title":"Clin Rheumatol"},{"issue":"1","key":"383_CR65","first-page":"33","volume":"21","author":"A Suzuki","year":"1994","unstructured":"Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, Irimajiri S, Fukuda J (1994) Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 21(1):33\u201336","journal-title":"J Rheumatol"},{"issue":"1","key":"383_CR66","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1148\/radiol.2321030174","volume":"232","author":"N Tanaka","year":"2004","unstructured":"Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, Emoto T, Matsumoto T, Lynch DA (2004) Rheumatoid arthritis-related lung diseases: CT findings. Radiology 232(1):81\u201391. https:\/\/doi.org\/10.1148\/radiol.2321030174","journal-title":"Radiology"},{"issue":"5","key":"383_CR67","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1378\/chest.09-0444","volume":"136","author":"EJ Kim","year":"2009","unstructured":"Kim EJ, Collard HR, King TE Jr (2009) Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 136(5):1397\u20131405. https:\/\/doi.org\/10.1378\/chest.09-0444","journal-title":"Chest"},{"issue":"9","key":"383_CR68","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","volume":"53","author":"CA Kelly","year":"2014","unstructured":"Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN, Dawson J, Sathi N, Ahmad Y, Koduri G, Young A, British Rheumatoid Interstitial Lung N (2014) Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2013a large multicentre UK study. Rheumatology (Oxford) 53(9):1676\u20131682. https:\/\/doi.org\/10.1093\/rheumatology\/keu165","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"383_CR69","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","volume":"106","author":"S Mori","year":"2012","unstructured":"Mori S, Koga Y, Sugimoto M (2012) Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med 106(11):1591\u20131599. https:\/\/doi.org\/10.1016\/j.rmed.2012.07.006","journal-title":"Respir Med"},{"issue":"135","key":"383_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/09059180.00008014","volume":"24","author":"M Shaw","year":"2015","unstructured":"Shaw M, Collins BF, Ho LA, Raghu G (2015) Rheumatoid arthritis-associated lung disease. Eur Respir Rev 24(135):1\u201316. https:\/\/doi.org\/10.1183\/09059180.00008014","journal-title":"Eur Respir Rev"},{"issue":"7","key":"383_CR71","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3899\/jrheum.131341","volume":"41","author":"J Zhu","year":"2014","unstructured":"Zhu J, Zhou Y, Chen X, Li J (2014) A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. J Rheumatol 41(7):1282\u20131289. https:\/\/doi.org\/10.3899\/jrheum.131341","journal-title":"J Rheumatol"},{"issue":"4","key":"383_CR72","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/art.37881","volume":"65","author":"L Harlow","year":"2013","unstructured":"Harlow L, Rosas IO, Gochuico BR, Mikuls TR, Dellaripa PF, Oddis CV, Ascherman DP (2013) Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum 65(4):869\u2013879. https:\/\/doi.org\/10.1002\/art.37881","journal-title":"Arthritis Rheum"},{"issue":"1","key":"383_CR73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/art.38904","volume":"67","author":"J Chen","year":"2015","unstructured":"Chen J, Doyle TJ, Liu Y, Aggarwal R, Wang X, Shi Y, Ge SX, Huang H, Lin Q, Liu W, Cai Y, Koontz D, Fuhrman CR, Golzarri MF, Liu Y, Hatabu H, Nishino M, Araki T, Dellaripa PF, Oddis CV, Rosas IO, Ascherman DP (2015) Biomarkers of rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol 67(1):28\u201338. https:\/\/doi.org\/10.1002\/art.38904","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"383_CR74","first-page":"315","volume":"5","author":"K Maniwa","year":"2000","unstructured":"Maniwa K, Ogushi F, Tani K, Ohmoto Y, Muraguchi M, Sone S (2000) Increased incidence of autoantibodies to interleukin-1a in rheumatoid arthritis with interstitial lung disease. Respirology 5(4):315\u2013320","journal-title":"Respirology"},{"issue":"5","key":"383_CR75","first-page":"1164","volume":"27","author":"H Nakajima","year":"2000","unstructured":"Nakajima H, Harigai M, Hara M, Hakoda M, Tokuda H, Sakai F, Kamatani N, Kashiwazaki S (2000) KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol 27(5):1164\u20131170","journal-title":"J Rheumatol"},{"issue":"3","key":"383_CR76","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1164\/arrd.1986.133.3.450","volume":"133","author":"JG Garcia","year":"1986","unstructured":"Garcia JG, Parhami N, Killam D, Garcia PL, Keogh BA (1986) Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis. Am Rev Respir Dis 133(3):450\u2013454. https:\/\/doi.org\/10.1164\/arrd.1986.133.3.450","journal-title":"Am Rev Respir Dis"},{"issue":"23","key":"383_CR77","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, Gonzalez-Perez MI, Mejia M, Buendia-Roldan I, Falfan-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Liote H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clement A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieude P (2018) MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N Engl J Med 379(23):2209\u20132219. https:\/\/doi.org\/10.1056\/NEJMoa1801562","journal-title":"N Engl J Med"},{"issue":"6","key":"383_CR78","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, Lee JS, King TE Jr, Collard HR (2010) Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 35(6):1322\u20131328. https:\/\/doi.org\/10.1183\/09031936.00092309","journal-title":"Eur Respir J"},{"issue":"3","key":"383_CR79","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.39971","volume":"69","author":"JA Zamora-Legoff","year":"2017","unstructured":"Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL (2017) Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol 69(3):542\u2013549. https:\/\/doi.org\/10.1002\/art.39971","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"383_CR80","first-page":"103","volume":"30","author":"JW Song","year":"2013","unstructured":"Song JW, Lee HK, Lee CK, Chae EJ, Jang SJ, Colby TV, Kim DS (2013) Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 30(2):103\u2013112","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"8","key":"383_CR81","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/thorax.56.8.622","volume":"56","author":"JK Dawson","year":"2001","unstructured":"Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR (2001) Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 56(8):622\u2013627","journal-title":"Thorax"},{"issue":"2","key":"383_CR82","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","volume":"47","author":"JJ Solomon","year":"2016","unstructured":"Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-Perez ER, Fischer A, Frankel SK, Hobbs SB, Huie TJ, Ketzer J, Mannina A, Olson AL, Russell G, Tsuchiya Y, Yunt ZX, Zelarney PT, Brown KK, Swigris JJ (2016) Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 47(2):588\u2013596. https:\/\/doi.org\/10.1183\/13993003.00357-2015","journal-title":"Eur Respir J"},{"issue":"9","key":"383_CR83","doi-asserted-by":"publisher","first-page":"e003132","DOI":"10.1136\/bmjopen-2013-003132","volume":"3","author":"H Hozumi","year":"2013","unstructured":"Hozumi H, Nakamura Y, Johkoh T, Sumikawa H, Colby TV, Kono M, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Suda T, Chida K (2013) Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open 3(9):e003132. https:\/\/doi.org\/10.1136\/bmjopen-2013-003132","journal-title":"BMJ Open"},{"issue":"4","key":"383_CR84","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.38322","volume":"66","author":"R Conway","year":"2014","unstructured":"Conway R, Low C, Coughlan RJ, O'Donnell MJ, Carey JJ (2014) Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheumatol 66(4):803\u2013812. https:\/\/doi.org\/10.1002\/art.38322","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"383_CR85","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Lokke A, Bendstrup E, Ellingsen T (2017) A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76(10):1700\u20131706. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211138","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"383_CR86","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1183\/09031936.00019210","volume":"37","author":"Y Tsuchiya","year":"2011","unstructured":"Tsuchiya Y, Takayanagi N, Sugiura H, Miyahara Y, Tokunaga D, Kawabata Y, Sugita Y (2011) Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 37(6):1411\u20131417. https:\/\/doi.org\/10.1183\/09031936.00019210","journal-title":"Eur Respir J"},{"issue":"5","key":"383_CR87","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3899\/jrheum.121043","volume":"40","author":"A Fischer","year":"2013","unstructured":"Fischer A, Brown KK, Du Bois RM, Frankel SK, Cosgrove GP, Fernandez-Perez ER, Huie TJ, Krishnamoorthy M, Meehan RT, Olson AL, Solomon JJ, Swigris JJ (2013) Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol 40(5):640\u2013646. https:\/\/doi.org\/10.3899\/jrheum.121043","journal-title":"J Rheumatol"},{"issue":"8","key":"383_CR88","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/rheumatology\/kex072","volume":"56","author":"MY Md Yusof","year":"2017","unstructured":"Md Yusof MY, Kabia A, Darby M, Lettieri G, Beirne P, Vital EM, Dass S, Emery P (2017) Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre. Rheumatology (Oxford) 56(8):1348\u20131357. https:\/\/doi.org\/10.1093\/rheumatology\/kex072","journal-title":"Rheumatology (Oxford)"},{"key":"383_CR89","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14306","author":"A Fui","year":"2019","unstructured":"Fui A, Bergantini L, Selvi E, Mazzei MA, Bennett D, Pieroni MG, Rottoli P, Bargagli E (2019) Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis. Intern Med J. https:\/\/doi.org\/10.1111\/imj.14306","journal-title":"Intern Med J"},{"issue":"1","key":"383_CR90","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semarthrit.2017.12.012","volume":"48","author":"C Fernandez-Diaz","year":"2018","unstructured":"Fernandez-Diaz C, Loricera J, Castaneda S, Lopez-Mejias R, Ojeda-Garcia C, Olive A, Rodriguez-Muguruza S, Carreira PE, Perez-Sandoval T, Retuerto M, Cervantes-Perez EC, Flores-Robles BJ, Hernandez-Cruz B, Urruticoechea A, Maiz-Alonso O, Arboleya L, Bonilla G, Hernandez-Rodriguez I, Palma D, Delgado C, Exposito-Molinero R, Ruibal-Escribano A, Alvarez-Rodriguez B, Blanco-Madrigal J, Bernal JA, Vela-Casasempere P, Rodriguez-Gomez M, Fito C, Ortiz-Sanjuan F, Narvaez J, Moreno M, Lopez-Corbeto M, Mena-Vazquez N, Aguilera-Cros C, Romero-Yuste S, Ordonez S, Villa-Blanco I, Gonzelez-Vela MC, Mora-Cuesta V, Palmou-Fontana N, Hernandez JL, Gonzalez-Gay MA, Blanco R (2018) Abatacept in patients with rheumatoid arthritis and interstitial lung disease: a national multicenter study of 63 patients. Semin Arthritis Rheum 48(1):22\u201327. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.12.012","journal-title":"Semin Arthritis Rheum"},{"key":"383_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14670","author":"A Manfredi","year":"2019","unstructured":"Manfredi A, Cassone G, Furini F, Gremese E, Venerito V, Atzeni F, Arrigoni E, Della Casa G, Cerri S, Govoni M, Petricca L, Iannone F, Salvarani C, Sebastiani M (2019) Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study. Intern Med J. https:\/\/doi.org\/10.1111\/imj.14670","journal-title":"Intern Med J"},{"issue":"5","key":"383_CR92","doi-asserted-by":"publisher","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","volume":"9","author":"P Kiely","year":"2019","unstructured":"Kiely P, Busby AD, Nikiphorou E, Sullivan K, Walsh DA, Creamer P, Dixey J, Young A (2019) Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open 9(5):e028466. https:\/\/doi.org\/10.1136\/bmjopen-2018-028466","journal-title":"BMJ Open"},{"issue":"3","key":"383_CR93","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/14397595.2018.1481566","volume":"29","author":"T Mochizuki","year":"2019","unstructured":"Mochizuki T, Ikari K, Yano K, Sato M, Okazaki K (2019) Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept. Mod Rheumatol 29(3):413\u2013417. https:\/\/doi.org\/10.1080\/14397595.2018.1481566","journal-title":"Mod Rheumatol"},{"issue":"18","key":"383_CR94","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK, Investigators IT (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718\u20131727. https:\/\/doi.org\/10.1056\/NEJMoa1908681","journal-title":"N Engl J Med"},{"issue":"7","key":"383_CR95","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.healun.2016.12.013","volume":"36","author":"AM Courtwright","year":"2017","unstructured":"Courtwright AM, El-Chemaly S, Dellaripa PF, Goldberg HJ (2017) Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease. J Heart Lung Transplant 36(7):763\u2013769. https:\/\/doi.org\/10.1016\/j.healun.2016.12.013","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"383_CR96","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.healun.2014.01.858","volume":"33","author":"A Yazdani","year":"2014","unstructured":"Yazdani A, Singer LG, Strand V, Gelber AC, Williams L, Mittoo S (2014) Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation. J Heart Lung Transplant 33(5):514\u2013520. https:\/\/doi.org\/10.1016\/j.healun.2014.01.858","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"383_CR97","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF (2011) Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 63(11):3439\u20133447. https:\/\/doi.org\/10.1002\/art.30513","journal-title":"Arthritis Rheum"},{"issue":"5","key":"383_CR98","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.chest.2016.04.007","volume":"150","author":"J Morisset","year":"2016","unstructured":"Morisset J, Johnson C, Rich E, Collard HR, Lee JS (2016) Management of myositis-related interstitial lung disease. Chest 150(5):1118\u20131128. https:\/\/doi.org\/10.1016\/j.chest.2016.04.007","journal-title":"Chest"},{"key":"383_CR99","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s40064-015-1013-8","volume":"4","author":"S Ikeda","year":"2015","unstructured":"Ikeda S, Arita M, Misaki K, Mishima S, Takaiwa T, Nishiyama A, Ito A, Furuta K, Yokoyama T, Tokioka F, Noyama M, Yoshioka H, Ishida T (2015) Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. Springerplus 4:240. https:\/\/doi.org\/10.1186\/s40064-015-1013-8","journal-title":"Springerplus"},{"issue":"7","key":"383_CR100","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/art.24631","volume":"60","author":"TJ Richards","year":"2009","unstructured":"Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR, Fertig N, Oddis CV, Kaminski N, Rosas IO, Ascherman DP (2009) Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 60(7):2183\u20132192. https:\/\/doi.org\/10.1002\/art.24631","journal-title":"Arthritis Rheum"},{"issue":"7","key":"383_CR101","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, Ryu JH (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164(7):1182\u20131185. https:\/\/doi.org\/10.1164\/ajrccm.164.7.2103110","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"383_CR102","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1590\/s1806-37132011000100015","volume":"37","author":"J Solomon","year":"2011","unstructured":"Solomon J, Swigris JJ, Brown KK (2011) Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol 37(1):100\u2013109. https:\/\/doi.org\/10.1590\/s1806-37132011000100015","journal-title":"J Bras Pneumol"},{"issue":"5","key":"383_CR103","doi-asserted-by":"publisher","first-page":"e0155381","DOI":"10.1371\/journal.pone.0155381","volume":"11","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wu G, Gao D, Liu G, Pan L, Ni L, Li Z, Wang Q (2016) Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. PLoS ONE 11(5):e0155381. https:\/\/doi.org\/10.1371\/journal.pone.0155381","journal-title":"PLoS ONE"},{"issue":"10","key":"383_CR104","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","volume":"11","author":"I Marie","year":"2012","unstructured":"Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP, Vittecoq O, Noel D, Mouthon L, Menard JF, Jouen F (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11(10):739\u2013745. https:\/\/doi.org\/10.1016\/j.autrev.2012.01.006","journal-title":"Autoimmun Rev"},{"key":"383_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8112013","author":"L Cavagna","year":"2019","unstructured":"Cavagna L, Trallero-Araguas E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scire C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blazquez Canamero MA, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O'Callaghan A, Castaneda S, Montecucco C, Gonzalez-Gay MA (2019) Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8112013","journal-title":"J Clin Med"},{"issue":"8","key":"383_CR106","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/acr.21992","volume":"65","author":"JC Hall","year":"2013","unstructured":"Hall JC, Casciola-Rosen L, Samedy LA, Werner J, Owoyemi K, Danoff SK, Christopher-Stine L (2013) Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res (Hoboken) 65(8):1307\u20131315. https:\/\/doi.org\/10.1002\/acr.21992","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"383_CR107","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.rmed.2015.07.004","volume":"109","author":"T Takada","year":"2015","unstructured":"Takada T, Aoki A, Asakawa K, Sakagami T, Moriyama H, Narita I, Sato S (2015) Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis. Respir Med 109(9):1174\u20131180. https:\/\/doi.org\/10.1016\/j.rmed.2015.07.004","journal-title":"Respir Med"},{"issue":"2","key":"383_CR108","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.resinv.2016.09.006","volume":"55","author":"T Fujisawa","year":"2017","unstructured":"Fujisawa T, Hozumi H, Kono M, Enomoto N, Nakamura Y, Inui N, Nakashima R, Imura Y, Mimori T, Suda T (2017) Predictive factors for long-term outcome in polymyositis\/dermatomyositis-associated interstitial lung diseases. Respir Investig 55(2):130\u2013137. https:\/\/doi.org\/10.1016\/j.resinv.2016.09.006","journal-title":"Respir Investig"},{"issue":"1","key":"383_CR109","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12931-019-1231-7","volume":"20","author":"A Sclafani","year":"2019","unstructured":"Sclafani A, D'Silva KM, Little BP, Miloslavsky EM, Locascio JJ, Sharma A, Montesi SB (2019) Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody. Respir Res 20(1):256. https:\/\/doi.org\/10.1186\/s12931-019-1231-7","journal-title":"Respir Res"},{"issue":"6","key":"383_CR110","doi-asserted-by":"publisher","first-page":"e98824","DOI":"10.1371\/journal.pone.0098824","volume":"9","author":"T Fujisawa","year":"2014","unstructured":"Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y, Inui N, Yokomura K, Koshimizu N, Toyoshima M, Shirai T, Yasuda K, Hayakawa H, Suda T (2014) Prognostic factors for myositis-associated interstitial lung disease. PLoS ONE 9(6):e98824. https:\/\/doi.org\/10.1371\/journal.pone.0098824","journal-title":"PLoS ONE"},{"key":"383_CR111","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.rmed.2017.07.010","volume":"130","author":"C Johnson","year":"2017","unstructured":"Johnson C, Rosen P, Lloyd T, Horton M, Christopher-Stine L, Oddis CV, Mammen AL, Danoff SK (2017) Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis. Respir Med 130:52\u201354. https:\/\/doi.org\/10.1016\/j.rmed.2017.07.010","journal-title":"Respir Med"},{"issue":"1","key":"383_CR112","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41598-020-58400-0","volume":"10","author":"R Lopez-Mejias","year":"2020","unstructured":"Lopez-Mejias R, Remuzgo-Martinez S, Genre F, Pulito-Cueto V, Rozas SMF, Llorca J, Fernandez DI, Cuesta VMM, Ortego-Centeno N, Gomez NP, Mera-Varela A, Martinez-Barrio J, Lopez-Longo FJ, Mijares V, Lera-Gomez L, Usetti MP, Laporta R, Perez V, Gafas AP, Gonzalez MAA, Calvo-Alen J, Romero-Bueno F, Sanchez-Pernaute O, Nuno L, Bonilla G, Balsa A, Hernandez-Gonzalez F, Grafia I, Prieto-Gonzalez S, Narvaez J, Trallero-Araguas E, Selva-O'Callaghan A, Gualillo O, Castaneda S, Cavagna L, Cifrian JM, Gonzalez-Gay MA (2020) Influence of MUC5B gene on antisynthetase syndrome. Sci Rep 10(1):1415. https:\/\/doi.org\/10.1038\/s41598-020-58400-0","journal-title":"Sci Rep"},{"issue":"6","key":"383_CR113","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/art.10794","volume":"47","author":"I Marie","year":"2002","unstructured":"Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47(6):614\u2013622. https:\/\/doi.org\/10.1002\/art.10794","journal-title":"Arthritis Rheum"},{"issue":"2","key":"383_CR114","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10165-007-0553-3","volume":"17","author":"K Takada","year":"2007","unstructured":"Takada K, Kishi J, Miyasaka N (2007) Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis\/polymyositis: a retrospective study. Mod Rheumatol 17(2):123\u2013130. https:\/\/doi.org\/10.1007\/s10165-007-0553-3","journal-title":"Mod Rheumatol"},{"issue":"1","key":"383_CR115","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10067-014-2803-z","volume":"34","author":"Y Ge","year":"2015","unstructured":"Ge Y, Peng Q, Zhang S, Zhou H, Lu X, Wang G (2015) Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review. Clin Rheumatol 34(1):99\u2013105. https:\/\/doi.org\/10.1007\/s10067-014-2803-z","journal-title":"Clin Rheumatol"},{"issue":"5","key":"383_CR116","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.chest.2019.05.023","volume":"156","author":"JA Huapaya","year":"2019","unstructured":"Huapaya JA, Silhan L, Pinal-Fernandez I, Casal-Dominguez M, Johnson C, Albayda J, Paik JJ, Sanyal A, Mammen AL, Christopher-Stine L, Danoff SK (2019) Long-term treatment with azathioprine and mycophenolate mofetil for myositis-related interstitial lung disease. Chest 156(5):896\u2013906. https:\/\/doi.org\/10.1016\/j.chest.2019.05.023","journal-title":"Chest"},{"issue":"8","key":"383_CR117","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/rheumatology\/kev004","volume":"54","author":"H Andersson","year":"2015","unstructured":"Andersson H, Sem M, Lund MB, Aalokken TM, Gunther A, Walle-Hansen R, Garen T, Molberg O (2015) Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease. Rheumatology (Oxford) 54(8):1420\u20131428. https:\/\/doi.org\/10.1093\/rheumatology\/kev004","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"383_CR118","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s10067-015-3065-0","volume":"34","author":"Y Ge","year":"2015","unstructured":"Ge Y, Zhou H, Shi J, Ye B, Peng Q, Lu X, Wang G (2015) The efficacy of tacrolimus in patients with refractory dermatomyositis\/polymyositis: a systematic review. Clin Rheumatol 34(12):2097\u20132103. https:\/\/doi.org\/10.1007\/s10067-015-3065-0","journal-title":"Clin Rheumatol"},{"issue":"4","key":"383_CR119","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3899\/jrheum.121026","volume":"40","author":"L Cavagna","year":"2013","unstructured":"Cavagna L, Caporali R, Abdi-Ali L, Dore R, Meloni F, Montecucco C (2013) Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease. J Rheumatol 40(4):484\u2013492. https:\/\/doi.org\/10.3899\/jrheum.121026","journal-title":"J Rheumatol"},{"issue":"3","key":"383_CR120","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00408-009-9146-6","volume":"187","author":"Y Suzuki","year":"2009","unstructured":"Suzuki Y, Hayakawa H, Miwa S, Shirai M, Fujii M, Gemma H, Suda T, Chida K (2009) Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis\/dermatomyositis. Lung 187(3):201\u2013206. https:\/\/doi.org\/10.1007\/s00408-009-9146-6","journal-title":"Lung"},{"issue":"3","key":"383_CR121","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1900045","volume":"381","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang X, Ye S (2019) Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease. N Engl J Med 381(3):291\u2013293. https:\/\/doi.org\/10.1056\/NEJMc1900045","journal-title":"N Engl J Med"},{"issue":"9","key":"383_CR122","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1016\/j.transproceed.2014.09.163","volume":"46","author":"H Ameye","year":"2014","unstructured":"Ameye H, Ruttens D, Benveniste O, Verleden GM, Wuyts WA (2014) Is lung transplantation a valuable therapeutic option for patients with pulmonary polymyositis? Experiences from the Leuven transplant cohort. Transplant Proc 46(9):3147\u20133153. https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.163","journal-title":"Transplant Proc"},{"issue":"2","key":"383_CR123","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3899\/jrheum.090507","volume":"37","author":"M Watanabe","year":"2010","unstructured":"Watanabe M, Naniwa T, Hara M, Arakawa T, Maeda T (2010) Pulmonary manifestations in Sjogren's syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol 37(2):365\u2013373. https:\/\/doi.org\/10.3899\/jrheum.090507","journal-title":"J Rheumatol"},{"issue":"11","key":"383_CR124","doi-asserted-by":"publisher","first-page":"e003569","DOI":"10.1136\/bmjopen-2013-003569","volume":"3","author":"C Nannini","year":"2013","unstructured":"Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL (2013) Primary Sjogren's syndrome 1976\u20132005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open 3(11):e003569. https:\/\/doi.org\/10.1136\/bmjopen-2013-003569","journal-title":"BMJ Open"},{"issue":"2","key":"383_CR125","doi-asserted-by":"publisher","first-page":"102447","DOI":"10.1016\/j.autrev.2019.102447","volume":"19","author":"G Sambataro","year":"2020","unstructured":"Sambataro G, Ferro F, Orlandi M, Sambataro D, Torrisi SE, Quartuccio L, Vancheri C, Baldini C, Matucci Cerinic M (2020) Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjgren's syndrome: a systematic review from the Italian Society of Rheumatology. Autoimmun Rev 19(2):102447. https:\/\/doi.org\/10.1016\/j.autrev.2019.102447","journal-title":"Autoimmun Rev"},{"issue":"1","key":"383_CR126","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1440-1843.2005.00627.x","volume":"10","author":"T Kurumagawa","year":"2005","unstructured":"Kurumagawa T, Kobayashi H, Motoyoshi K (2005) Potential involvement of subclinical Sjogren's syndrome in various lung diseases. Respirology 10(1):86\u201391. https:\/\/doi.org\/10.1111\/j.1440-1843.2005.00627.x","journal-title":"Respirology"},{"issue":"2","key":"383_CR127","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1378\/chest.88.2.226","volume":"88","author":"SH Constantopoulos","year":"1985","unstructured":"Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM (1985) Respiratory manifestations in primary Sjogren's syndrome. A clinical, functional, and histologic study. Chest 88(2):226\u2013229","journal-title":"Chest"},{"issue":"3","key":"383_CR128","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1378\/chest.90.3.370","volume":"90","author":"MP Papathanasiou","year":"1986","unstructured":"Papathanasiou MP, Constantopoulos SH, Tsampoulas C, Drosos AA, Moutsopoulos HM (1986) Reappraisal of respiratory abnormalities in primary and secondary Sjogren's syndrome. A controlled study. Chest 90(3):370\u2013374","journal-title":"Chest"},{"issue":"7","key":"383_CR129","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/ard.44.7.455","volume":"44","author":"C Vitali","year":"1985","unstructured":"Vitali C, Tavoni A, Viegi G, Begliomini E, Agnesi A, Bombardieri S (1985) Lung involvement in Sjogren's syndrome: a comparison between patients with primary and with secondary syndrome. Ann Rheum Dis 44(7):455\u2013461","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"383_CR130","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","volume":"52","author":"O Palm","year":"2013","unstructured":"Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aalokken TM, Gran JT (2013) Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality\u2013a retrospective study based on registry data. Rheumatology (Oxford) 52(1):173\u2013179. https:\/\/doi.org\/10.1093\/rheumatology\/kes311","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"383_CR131","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","volume":"54","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals M, Brito-Zeron P, Seror R, Bootsma H, Bowman SJ, Dorner T, Gottenberg JE, Mariette X, Theander E, Bombardieri S, De Vita S, Mandl T, Ng WF, Kruize A, Tzioufas A, Vitali C, Force ESST (2015) Characterization of systemic disease in primary Sjogren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford) 54(12):2230\u20132238. https:\/\/doi.org\/10.1093\/rheumatology\/kev200","journal-title":"Rheumatology (Oxford)"},{"key":"383_CR132","doi-asserted-by":"publisher","first-page":"105895","DOI":"10.1016\/j.rmed.2020.105895","volume":"163","author":"C Buvry","year":"2020","unstructured":"Buvry C, Cassagnes L, Tekath M, Artigues M, Pereira B, Rieu V, Le Guenno G, Tournadre A, Ruivard M, Grobost V (2020) Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjogren syndrome. Respir Med 163:105895. https:\/\/doi.org\/10.1016\/j.rmed.2020.105895","journal-title":"Respir Med"},{"issue":"9","key":"383_CR133","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/ard.59.9.709","volume":"59","author":"BK Davidson","year":"2000","unstructured":"Davidson BK, Kelly CA, Griffiths ID (2000) Ten year follow up of pulmonary function in patients with primary Sjogren's syndrome. Ann Rheum Dis 59(9):709\u2013712","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"383_CR134","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/art.1780301104","volume":"30","author":"PY Hatron","year":"1987","unstructured":"Hatron PY, Wallaert B, Gosset D, Tonnel AB, Gosselin B, Voisin C, Devulder B (1987) Subclinical lung inflammation in primary Sjogren's syndrome: relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum 30(11):1226\u20131231","journal-title":"Arthritis Rheum"},{"issue":"6","key":"383_CR135","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1378\/chest.99.6.1394","volume":"99","author":"YA Dalavanga","year":"1991","unstructured":"Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM (1991) Alveolitis correlates with clinical pulmonary involvement in primary Sjogren's syndrome. Chest 99(6):1394\u20131397","journal-title":"Chest"},{"issue":"9","key":"383_CR136","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00296-005-0092-1","volume":"26","author":"YA Dalavanga","year":"2006","unstructured":"Dalavanga YA, Voulgari PV, Georgiadis AN, Leontaridi C, Katsenos S, Vassiliou M, Drosos AA, Constantopoulos SH (2006) Lymphocytic alveolitis: a surprising index of poor prognosis in patients with primary Sjogren's syndrome. Rheumatol Int 26(9):799\u2013804. https:\/\/doi.org\/10.1007\/s00296-005-0092-1","journal-title":"Rheumatol Int"},{"issue":"3","key":"383_CR137","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/rheumatology\/37.3.263","volume":"37","author":"F Salaffi","year":"1998","unstructured":"Salaffi F, Manganelli P, Carotti M, Baldelli S, Blasetti P, Subiaco S, Binci MC, Bichi Secchi E, Amici F, Cervini C (1998) A longitudinal study of pulmonary involvement in primary Sjogren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography. Br J Rheumatol 37(3):263\u2013269","journal-title":"Br J Rheumatol"},{"issue":"9","key":"383_CR138","doi-asserted-by":"publisher","first-page":"e73774","DOI":"10.1371\/journal.pone.0073774","volume":"8","author":"Y Enomoto","year":"2013","unstructured":"Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Fukuda Y, Yanagawa N, Sakai F, Baba T, Nagaoka S, Ogura T (2013) Prognostic factors in interstitial lung disease associated with primary Sjogren's syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS ONE 8(9):e73774. https:\/\/doi.org\/10.1371\/journal.pone.0073774","journal-title":"PLoS ONE"},{"issue":"6","key":"383_CR139","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","volume":"72","author":"JE Gottenberg","year":"2013","unstructured":"Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, Sibilia J, Zarnitsky C, Carli P, Rist S, Gaudin P, Salliot C, Piperno M, Deplas A, Breban M, Lequerre T, Richette P, Ghiringhelli C, Hamidou M, Ravaud P, Mariette X, Club Rhumatismes et I, The French Society of R (2013) Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis 72(6):1026\u20131031. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202293","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"383_CR140","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","volume":"130","author":"JG Parambil","year":"2006","unstructured":"Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH (2006) Interstitial lung disease in primary Sjogren syndrome. Chest 130(5):1489\u20131495. https:\/\/doi.org\/10.1378\/chest.130.5.1489","journal-title":"Chest"},{"issue":"3 Pt 1","key":"383_CR141","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1164\/ajrccm.154.3.8810621","volume":"154","author":"D Deheinzelin","year":"1996","unstructured":"Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR (1996) Interstitial lung disease in primary Sjogren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 154(3 Pt 1):794\u2013799. https:\/\/doi.org\/10.1164\/ajrccm.154.3.8810621","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"383_CR142","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0961203307079042","volume":"16","author":"Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS, Group LS","year":"2007","unstructured":"Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS, Group LS (2007) Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage. Lupus 16(6):410\u2013417. https:\/\/doi.org\/10.1177\/0961203307079042","journal-title":"Lupus"},{"issue":"1","key":"383_CR143","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1440-1843.2002.00361.x","volume":"7","author":"M Nakano","year":"2002","unstructured":"Nakano M, Hasegawa H, Takada T, Ito S, Muramatsu Y, Satoh M, Suzuki E, Gejyo F (2002) Pulmonary diffusion capacity in patients with systemic lupus erythematosus. Respirology 7(1):45\u201349","journal-title":"Respirology"},{"issue":"2","key":"383_CR144","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1055\/s-0034-1371537","volume":"35","author":"S Mittoo","year":"2014","unstructured":"Mittoo S, Fell CD (2014) Pulmonary manifestations of systemic lupus erythematosus. Semin Respir Crit Care Med 35(2):249\u2013254. https:\/\/doi.org\/10.1055\/s-0034-1371537","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"383_CR145","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/BF01451282","volume":"17","author":"S Jacobsen","year":"1998","unstructured":"Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, van Overeem HG, Skaarup B, Hansen TM, Podenphant J, Halberg P (1998) A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 17(6):468\u2013477","journal-title":"Clin Rheumatol"},{"issue":"1","key":"383_CR146","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semarthrit.2007.09.005","volume":"38","author":"SS Lee","year":"2008","unstructured":"Lee SS, Singh S, Link K, Petri M (2008) High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. Semin Arthritis Rheum 38(1):41\u201354. https:\/\/doi.org\/10.1016\/j.semarthrit.2007.09.005","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"383_CR147","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00005792-197509000-00003","volume":"54","author":"RA Matthay","year":"1975","unstructured":"Matthay RA, Schwarz MI, Petty TL, Stanford RE, Gupta RC, Sahn SA, Steigerwald JC (1975) Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 54(5):397\u2013409. https:\/\/doi.org\/10.1097\/00005792-197509000-00003","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"383_CR148","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/rheumatology\/35.3.248","volume":"35","author":"T Stoll","year":"1996","unstructured":"Stoll T, Seifert B, Isenberg DA (1996) SLICC\/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 35(3):248\u2013254","journal-title":"Br J Rheumatol"},{"issue":"1","key":"383_CR149","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0049-0172(90)90094-V","volume":"20","author":"L Weinrib","year":"1990","unstructured":"Weinrib L, Sharma OP, Quismorio FP Jr (1990) A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 20(1):48\u201356","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"383_CR150","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.rdc.2005.04.004","volume":"31","author":"EL Greidinger","year":"2005","unstructured":"Greidinger EL, Hoffman RW (2005) Autoantibodies in the pathogenesis of mixed connective tissue disease. Rheum Dis Clin North Am 31(3):437\u2013450. https:\/\/doi.org\/10.1016\/j.rdc.2005.04.004","journal-title":"Rheum Dis Clin North Am"},{"issue":"12","key":"383_CR151","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1136\/annrheumdis-2011-201253","volume":"71","author":"R Gunnarsson","year":"2012","unstructured":"Gunnarsson R, Aalokken TM, Molberg O, Lund MB, Mynarek GK, Lexberg AS, Time K, Dhainaut AS, Bertelsen LT, Palm O, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Proven A, Garabet LS, Gran JT (2012) Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis 71(12):1966\u20131972. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201253","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"383_CR152","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/rheumatology\/keh575","volume":"44","author":"E Bodolay","year":"2005","unstructured":"Bodolay E, Szekanecz Z, Devenyi K, Galuska L, Csipo I, Vegh J, Garai I, Szegedi G (2005) Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) 44(5):656\u2013661. https:\/\/doi.org\/10.1093\/rheumatology\/keh575","journal-title":"Rheumatology (Oxford)"},{"issue":"48","key":"383_CR153","first-page":"2435","volume":"146","author":"J Vegh","year":"2005","unstructured":"Vegh J, Szilasi M, Soos G, Devenyi K, Dezso B, Soltesz P, Zeher M, Szegedi G, Bodolay E (2005) Interstitial lung disease in mixed connective tissue disease. Orv Hetil 146(48):2435\u20132443","journal-title":"Orv Hetil"},{"issue":"2","key":"383_CR154","first-page":"234","volume":"33","author":"L Kawano-Dourado","year":"2015","unstructured":"Kawano-Dourado L, Baldi BG, Kay FU, Dias OM, Gripp TE, Gomes PS, Fuller R, Caleiro MT, Kairalla RA, Carvalho CR (2015) Pulmonary involvement in long-term mixed connective tissue disease: functional trends and image findings after 10 years. Clin Exp Rheumatol 33(2):234\u2013240","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"383_CR155","first-page":"648","volume":"36","author":"N Narula","year":"2018","unstructured":"Narula N, Narula T, Mira-Avendano I, Wang B, Abril A (2018) Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement. Clin Exp Rheumatol 36(4):648\u2013651","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"383_CR156","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","volume":"55","author":"R Gunnarsson","year":"2016","unstructured":"Gunnarsson R, El-Hage F, Aalokken TM, Reiseter S, Lund MB, Garen T, Msg N, Molberg O (2016) Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease. Rheumatology (Oxford) 55(1):103\u2013108. https:\/\/doi.org\/10.1093\/rheumatology\/kev300","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"383_CR157","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.rmed.2008.12.018","volume":"103","author":"MN Fagundes","year":"2009","unstructured":"Fagundes MN, Caleiro MT, Navarro-Rodriguez T, Baldi BG, Kavakama J, Salge JM, Kairalla R, Carvalho CR (2009) Esophageal involvement and interstitial lung disease in mixed connective tissue disease. Respir Med 103(6):854\u2013860. https:\/\/doi.org\/10.1016\/j.rmed.2008.12.018","journal-title":"Respir Med"},{"issue":"6","key":"383_CR158","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1183\/13993003.01565-2015","volume":"47","author":"JM Oldham","year":"2016","unstructured":"Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, Husain AN, Montner S, Chung JH, Cottin V, Fischer A, Noth I, Vij R, Strek ME (2016) Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 47(6):1767\u20131775. https:\/\/doi.org\/10.1183\/13993003.01565-2015","journal-title":"Eur Respir J"},{"key":"383_CR159","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.rmed.2016.09.002","volume":"119","author":"S Chartrand","year":"2016","unstructured":"Chartrand S, Swigris JJ, Stanchev L, Lee JS, Brown KK, Fischer A (2016) Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience. Respir Med 119:150\u2013154. https:\/\/doi.org\/10.1016\/j.rmed.2016.09.002","journal-title":"Respir Med"},{"key":"383_CR160","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.rmed.2016.10.017","volume":"123","author":"K Ahmad","year":"2017","unstructured":"Ahmad K, Barba T, Gamondes D, Ginoux M, Khouatra C, Spagnolo P, Strek M, Thivolet-Bejui F, Traclet J, Cottin V (2017) Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med 123:56\u201362. https:\/\/doi.org\/10.1016\/j.rmed.2016.10.017","journal-title":"Respir Med"},{"issue":"1","key":"383_CR161","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12890-017-0453-z","volume":"17","author":"Y Ito","year":"2017","unstructured":"Ito Y, Arita M, Kumagai S, Takei R, Noyama M, Tokioka F, Nishimura K, Koyama T, Notohara K, Ishida T (2017) Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features. BMC Pulm Med 17(1):111. https:\/\/doi.org\/10.1186\/s12890-017-0453-z","journal-title":"BMC Pulm Med"},{"key":"383_CR162","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.rmed.2019.03.011","volume":"150","author":"G Sambataro","year":"2019","unstructured":"Sambataro G, Sambataro D, Torrisi SE, Vancheri A, Colaci M, Pavone M, Pignataro F, Del Papa N, Palmucci S, Vancheri C (2019) Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients. Respir Med 150:154\u2013160. https:\/\/doi.org\/10.1016\/j.rmed.2019.03.011","journal-title":"Respir Med"},{"issue":"2","key":"383_CR163","doi-asserted-by":"publisher","first-page":"102451","DOI":"10.1016\/j.autrev.2019.102451","volume":"19","author":"M Sebastiani","year":"2020","unstructured":"Sebastiani M, Cassone G, De Pasquale L, Cerri S, Della Casa G, Vacchi C, Luppi F, Salvarani C, Manfredi A (2020) Interstitial pneumonia with autoimmune features: a single center prospective follow-up study. Autoimmun Rev 19(2):102451. https:\/\/doi.org\/10.1016\/j.autrev.2019.102451","journal-title":"Autoimmun Rev"},{"issue":"1","key":"383_CR164","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.chest.2019.08.2175","volume":"157","author":"G Sambataro","year":"2020","unstructured":"Sambataro G, Vancheri A, Torrisi SE, Colaci M, Pavone M, Libra A, Martorana E, Rosso R, Pignataro F, Del Papa N, Malatino L, Palmucci S, Sambataro D, Vancheri C (2020) The morphological domain does not affect the rate of progression to defined autoimmune diseases in patients with interstitial pneumonia with autoimmune features. Chest 157(1):238\u2013242. https:\/\/doi.org\/10.1016\/j.chest.2019.08.2175","journal-title":"Chest"},{"issue":"5","key":"383_CR165","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.23571","volume":"59","author":"M Fathi","year":"2008","unstructured":"Fathi M, Vikgren J, Boijsen M, Tylen U, Jorfeldt L, Tornling G, Lundberg IE (2008) Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 59(5):677\u2013685. https:\/\/doi.org\/10.1002\/art.23571","journal-title":"Arthritis Rheum"},{"issue":"1","key":"383_CR166","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/rheumatology\/kes289","volume":"52","author":"OA Moore","year":"2013","unstructured":"Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, Youssef P, Nash P, Zochling J, Proudman SM, Stevens W, Nikpour M (2013) Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford) 52(1):155\u2013160. https:\/\/doi.org\/10.1093\/rheumatology\/kes289","journal-title":"Rheumatology (Oxford)"},{"key":"383_CR167","doi-asserted-by":"publisher","DOI":"10.1183\/13993003","author":"P Christopher","year":"2019","unstructured":"Christopher P, Denton CJFL, Goldin J, Kim G, Kuwana M, Allanore Y, Batalov A, Butrimiene I, Carreira P, Matucci-Cerinic M, Distler O, Kaliterna DM, Mihai C-M, Mogensen M, Olesi\u0144ska M, Pope JE, Riemekasten G, Rodriguez-Reyne TS, Santos MJ, Van Laar J, Spotswood H, Siegel J, Jahreis A, Furst DE, Khanna D (2019) Lung function preservation in a phase 3 trial of tocilizumab (TCZ) in systemic sclerosis (SSc). Eur Respir J. https:\/\/doi.org\/10.1183\/13993003","journal-title":"Eur Respir J"},{"issue":"2","key":"383_CR168","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","volume":"8","author":"TM Maher","year":"2020","unstructured":"Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Samara K, Gilberg F, Cottin V (2020) Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med 8(2):147\u2013157. https:\/\/doi.org\/10.1016\/S2213-2600(19)30341-8","journal-title":"Lancet Respir Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00383-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-020-00383-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00383-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T19:43:54Z","timestamp":1628624634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-020-00383-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":168,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["383"],"URL":"https:\/\/doi.org\/10.1007\/s00408-020-00383-w","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"assertion":[{"value":"4 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}